Connecting the microbiome to obesity-associated cancers Kai-Jye Lou BriefCommunication Pages: 743 - 743
Cytosolic branched chain amino-acid transaminase 1 (BCAT1); isocitrate dehydrogenase 1 (IDH1) BriefCommunication Pages: 748 - 748
Potassium channel KCa2.3 (KCNN3; SK3); transmembrane protein 142A (ORAI1; TMEM142A; CRACM1) BriefCommunication Pages: 753 - 753
Mycobacterium tuberculosis long-chain fatty acid–CoA ligase (fadD32) BriefCommunication Pages: 764 - 764
μ-Opioid receptor (OPRM1; MOR); metabotropic glutamate receptor subtype 5 (mGluR5; GRM5) BriefCommunication Pages: 765 - 765
Quantification of clustered, regularly interspaced short palindromic repeats (CRISPR)-based editing system specificity BriefCommunication Pages: 768 - 768
Computational model for predicting P glycoprotein (MDR1; ABCB1; P-gp; CD243) substrates BriefCommunication Pages: 769 - 769
Mouse model for prostate cancer driven by v-ets erythroblastosis virus E26 oncogene homolog (ERG) translocations BriefCommunication Pages: 770 - 770
Mouse models for choroidal neovascularization (CNV) and age-related macular degeneration (AMD) BriefCommunication Pages: 771 - 771
Monoacyl lipopeptide agonist of toll-like receptor 2 (TLR2) as a vaccine adjuvant BriefCommunication Pages: 773 - 773
Platform for maturation of human pluripotent stem cell–derived cardiomyocytes BriefCommunication Pages: 774 - 774
Self-assembling, osteogenic, polymer-based coating to prevent joint implant failure BriefCommunication Pages: 775 - 775
Androgen receptor mutations that convey resistance to second-generation anti–androgen receptor compounds BriefCommunication Pages: 776 - 776
Galectin-1 (LGALS1) as a prognostic marker of early onset pre-eclampsia BriefCommunication Pages: 777 - 777